StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sanofi (SNY) Issues Commentary on Medivation's (MDVN) Rejection of Takeover Proposal; Remains Committed to Combination
April 29, 2016 9:06 AM
Sanofi (NYSE: SNY) commented on Medivation, Inc.'s (Nasdaq: MDVN) rejection of Sanofi's non-binding all-cash proposal to acquire Medivation for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Mergers and Acquisitions
Next Articles
Medivation (MDVN) PT Raised to $63 at Credit Suisse on M&A Valuation
May 3, 2016 7:27 AM
Stifel Raises Medivation Inc (MDVN) PT to $66 with Company In Play
May 2, 2016 7:19 AM
Sanofi Comments on Medivation's Rejection of Proposal
April 29, 2016 9:05 AM
Medivation (MDVN) Rejects Sanofi's (SNY) Unsolicited Proposal
April 29, 2016 8:46 AM
Medivation's Board of Directors Unanimously Rejects Sanofi's Unsolicited Proposal
April 29, 2016 8:45 AM
Sanofi, Medivation dig in for big biotech takeover battle
April 29, 2016 4:11 AM
Form DEFA14A MEDIVATION, INC.
April 28, 2016 5:02 PM
Form DEF 14A MEDIVATION, INC. For: Jun 22
April 28, 2016 4:57 PM
